Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Strategies for larger families focus on prioritization and flexible allocations. Learn how to tailor a zero-based plan to multiple dependents.
27,842 articlesA cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Treasury's crypto policy lead is pushing for CLARITY Act passage by summer 2026 and signaling a cautious, deliberatel...
The NEOS QQQI ETF offers a high monthly yield, but hidden costs could erode capital in calmer markets. This report ex...
A New York man was sentenced to 15 months in federal prison for running a Telegram-based crypto fraud that netted abo...
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
HYSA interest is taxed as ordinary income in the year it is credited, not when you spend it. There are no special rat...
An ex-Mt. Gox chief proposes a hard fork aimed at reclaiming billions in stolen Bitcoin, setting off a debate over te...
Insiders linked to the TRUMP memecoin moved millions of tokens to Binance as the price slumped to a new low, signalin...
In a hypothetical scenario, Gemini faces a class-action suit after pivoting to prediction markets. Investors wonder i...
Bernstein boosts its ServiceNow price target to $236 after the company's Analyst Day, underscoring margin upside even...
As automation advances, hospitality leaders argue that Gen Z workers want ai-proof jobs with purpose. A 50-property c...
Sen. Elizabeth Warren is demanding answers from Bilt Rewards after reports that rent and mortgage payments were disru...